Whole new set of stacked LCT pegmatites unwrapped at Koba Resources’ Blue Moon prospect
LCT pegmatites have been discovered at the Whitlock lithium project in Manitoba, Canada Pegmatites mapped over 70m and near surface Blue Moon is just 8km [more…]
ASX Small Caps Lunch Wrap: Which little piggy didn’t quite make it to market this week?
Local markets are up 0.15% around lunchtime today, as yesterday’s rush on mining stocks continued into this morning’s session, and local investors decided that today [more…]
Recharge Metals adds priority pegmatite targets to its Canadian lithium express line
Surface sampling confirms prospectivity of LCT pegmatite systems Two high-priority targets across 3.6km and 3.2km strikes have been defined Future work to begin during the [more…]
What’s in store for 2024: Alvo Minerals
Stockhead’s Ashtyn Hiron sits down with Alvo Minerals (ASX:ALV) managing director Rob Smakman to close the books on 2023 and gain a sneak peek into what’s [more…]
Resources Top 4: Lithium gun PMT’s board plays musical chairs in Quebec; NGX up on African graphite
Patriot Battery Metals’ Ken Brinsden is finally pulling up stumps… to move to Quebec and head the company from there Malawi-focused graphite hunter NGX is [more…]
Mt Malcolm Mines to put more shine into Golden Crown with upcoming maiden resource
Mt Malcolm Mines starts RC drilling to define a maiden gold resource at Golden Crown Golden Crown has historical high-grade gold production and drill intersections [more…]
Ground Breakers: Is that a whiff of lithium positivity we smell in the air? Oh wait, sorry Sayona
MinRes has trimmed unit costs in an impressive update from its lithium business Chris Ellison’s company will back a joint bid for Azure Minerals from [more…]
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
Memphasys drops 30pc after trial results disappoint investors Echo IQ licences its cardio decision-support tool, EchoSolv, to Respiri Truscreen’s sales up 40pc in Q3 [more…]
Neurotech moves to show economic advantage of autism treatment as Phase II/III trial results due soon
Neurotech views lead drug NTI164 as a promising, cost-effective and long-term treatment for ASD Health economic consultancy appointed to evaluate economic benefits of treating ASD [more…]
Western Yilgarn looking to expand Bulga footprint via potential JV with Fleet Street
Western Yilgarn has entered into a binding JV term sheet with Fleet Street Holdings for rights to access four tenements The four tenements provide the [more…]
